{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:19:20Z","timestamp":1775161160737,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.hjc.2020.10.008","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T21:48:09Z","timestamp":1605044889000},"page":"185-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4016","authenticated-orcid":false,"given":"Filippos","family":"Triposkiadis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos Dean","family":"Boudoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-3946","authenticated-orcid":false,"given":"Andrew","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harisios","family":"Boudoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hjc.2020.10.008_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000371572","article-title":"The shortcomings of clinical practice guidelines","volume":"130","author":"Boudoulas","year":"2015","journal-title":"Cardiology"},{"issue":"8","key":"10.1016\/j.hjc.2020.10.008_bib2","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.hjc.2020.10.008_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/M20-2076","article-title":"Biomedical Research in Times of Emergency: Lessons From History","volume":"173","author":"Doroshow","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hjc.2020.10.008_bib4","first-page":"241","volume":"34","author":"Wooley","year":"1993","journal-title":"Clinician. Hellenic J Cardiol"},{"issue":"6965","key":"10.1016\/j.hjc.2020.10.008_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.hjc.2020.10.008_bib6","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.hjc.2020.10.008_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41569-020-0368-x","article-title":"Interaction between RAAS inhibitors and ACE2 in the context of COVID-19","volume":"17","author":"Mourad","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"10.1016\/j.hjc.2020.10.008_bib8","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.hjc.2020.10.008_bib9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hjc.2020.10.008_bib10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","article-title":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19","volume":"116","author":"Kreutz","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hjc.2020.10.008_bib11","series-title":"Fallacies","year":"2020"},{"key":"10.1016\/j.hjc.2020.10.008_bib12","series-title":"Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic","year":"2020"},{"issue":"19","key":"10.1016\/j.hjc.2020.10.008_bib13","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","article-title":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors","volume":"41","author":"Sama","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hjc.2020.10.008_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.hjc.2020.10.008_bib15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.kint.2020.04.009","article-title":"Blockade of SARS-CoV-2 infection by recombinant soluble ACE2","volume":"97","author":"Alhenc-Gelas","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.hjc.2020.10.008_bib16","series-title":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","year":"2020"},{"issue":"33","key":"10.1016\/j.hjc.2020.10.008_bib17","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.hjc.2020.10.008_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.hjc.2020.10.008_bib19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.hjc.2020.10.008_bib20","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe2012924","article-title":"Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19","author":"Jarcho","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.hjc.2020.10.008_bib21","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMc2021225","article-title":"Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hjc.2020.10.008_bib22","article-title":"RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis","author":"Mehra","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hjc.2020.10.008_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.therap.2018.11.001","article-title":"The limitations of observation studies for decision making regarding drugs efficacy and safety","volume":"74","author":"Gueyffier","year":"2019","journal-title":"Therapie"},{"issue":"5","key":"10.1016\/j.hjc.2020.10.008_bib24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacc.2020.05.069","article-title":"Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week","volume":"76","author":"Fanaroff","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hjc.2020.10.008_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002556","article-title":"Comparing hormone therapy effects in two RCTs and two large observational studies that used similar methods for comprehensive data collection and outcome assessment","volume":"3","author":"Hartz","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.hjc.2020.10.008_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10741-014-9453-8","article-title":"Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis","volume":"20","author":"Bavishi","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"5","key":"10.1016\/j.hjc.2020.10.008_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.hjc.2017.05.001","article-title":"The endlessness evolution of medicine, continuous increase in life expectancy and constant role of the physician","volume":"58","author":"Boudoulas","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2020.10.008_bib28","article-title":"Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications","author":"Triposkiadis","year":"2020","journal-title":"Heart Fail Rev"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966620302499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966620302499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:14:18Z","timestamp":1761099258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966620302499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1109966620302499"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2020.10.008","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}